Background The reported prevalence and burden of coronary artery disease in young adults varies markedly in published studies ...
A new study found that a non-invasive, AI enabled Coronary Computer Tomography Angiography effectively identified stenosis equally well or better than the conventional gold standard of invasive ...
Ever since the National Institute for Health and Care Excellence (NICE) gave priority to coronary computed tomography angiography (CCTA) as the test of choice for patients presenting with recent-onset ...
MADRID, Spain—Routine use of CT angiography after PCI for left main coronary artery disease does not lower the risk of major adverse cardiac events, results of the PULSE trial show. There was a signal ...
An artificial intelligence (AI)-based assessment of coronary CT angiography outperformed visual assessment by human readers and demonstrated superior agreement with a quantitative coronary angiography ...
Coronary CT angiography for the suspected progression of known coronary artery disease in a 60-year-old female patient. Curved multiplanar reconstructions with 0.6- (yellow outline), 0.4- (blue ...
Elucid, an innovator in AI-powered coronary CT angiography (CCTA) analysis, today announced first patient enrollment in AI-PREDICT, a retrospective, international, multicenter study designed to ...
"These extended and sustained benefits appear to be primarily driven by a reduction in the rate of non-fatal MI, suggesting that the principal benefit of CCTA [coronary CT angiography] is driven by ...
Catalyst MedTech, a leader in nuclear medicine and molecular imaging solutions, today announced a strategic channel partnership with APQ Health to expand access to advanced cardiac CT angiography ...
Please provide your email address to receive an email when new articles are posted on . In patients with stable chest pain and intermediate pretest probability of CAD, risk for major adverse CV events ...
Ultrahigh-spatial-resolution photon-counting detector CT improved assessment of coronary artery disease (CAD), allowing for reclassification to a lower disease category in 54% of patients, according ...